ADHD Medication With a Heart Murmur, Mitral Valve Prolapse, or Structural Heart Disease

The stimulant labels advise avoiding use in people with known structural cardiac abnormalities, and none of the four major labels defines the term or gives examples.^{1, 2, 3, 4} In a chart review of 831 children and young people with congenital heart disease who took stimulants, one adverse cardiovascular event was identified.⁵

A murmur is a finding on examination that needs a diagnosis behind it. UK guidance from NICE lists "a murmur heard on cardiac examination" among the reasons to refer for a cardiology opinion before starting ADHD medication.⁶ A PubMed search run in November 2026 for mitral valve prolapse with stimulant medication returned no studies.

What the labels say about structural heart disease

The Adderall XR, Vyvanse and Concerta labels carry the same sentence, which advises avoiding use "in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease."^{1, 2, 3} I've covered how that sentence applies to high blood pressure and other heart conditions on a separate page.

The Ritalin label adds one word. It advises avoiding use in patients with "known serious structural cardiac abnormalities."⁴ Adderall XR contains mixed amphetamine salts and Vyvanse contains lisdexamfetamine; Concerta and Ritalin are methylphenidate products.^{1, 2, 3, 4}

In each label this advice sits under Warnings and Precautions. The contraindications sections list hypersensitivity and use with a monoamine oxidase inhibitor (MAOI). None of the four labels names mitral valve prolapse, valve disease, septal defects or congenital heart disease.^{1, 2, 3, 4} The Ritalin Medication Guide asks patients to tell the prescriber before starting about "heart problems, heart disease, heart defects, or high blood pressure."⁴

Why the warning exists

A 2008 review summarized reports of sudden death during stimulant treatment from January 1992 to February 2005. There were 20 reports with amphetamine products, 14 in children, of whom 6 had structural cardiovascular abnormalities or other predisposing factors. There were 18 with methylphenidate, 14 in children, of whom 6 had structural abnormalities.⁷

These were spontaneous reports with no denominator, so they can't measure risk. The review stated that a causal link "has not been established" and that careful pretreatment assessment was recommended because of concern about people with structural abnormalities.⁷ According to a 2010 review, the American Heart Association and the American Academy of Pediatrics both recommend a history and examination focused on cardiovascular disease. On ECGs, the AHA calls one reasonable but not mandatory, and the AAP does not recommend them routinely.⁸

Can you take Adderall with a heart murmur?

The UK NICE guideline lists nine findings that should prompt a cardiology opinion before ADHD medication starts. Besides a murmur, they include a history of congenital heart disease or previous cardiac surgery, and sudden death in a first-degree relative under 40 years suggesting a cardiac disease.⁶

A 2022 review described the same practice: cardiology opinion "is often sought" before ADHD medication when there are cardiac murmurs on examination, a history of cardiovascular disease, sudden cardiac death in a first relative, high heart rate or blood pressure, or abnormal ECG features.⁹ The cardiologist's diagnosis then informs whether the label's structural warning applies.

Can ADHD medication cause a heart murmur?

Cardiac murmur appears in the Concerta label's list of adverse reactions that occurred in less than 2% of patients ages 6 to 65 in its clinical ADHD trials.³ The list records events observed during the trials, without a cause assigned to each one.

Mitral valve prolapse and valve disease

The 2022 review addressed valve disease directly. Its authors wrote that "many cardiovascular diagnoses are not contraindications to commencing ADHD medications (e.g., valvular stenosis or regurgitation, atrial or ventricular septal defects etc.)," while management in serious cardiac disease such as hypertrophic cardiomyopathy "is still a dilemma."⁹ That is the authors' view in a narrative review, and it doesn't mention mitral valve prolapse by name.

The same review flagged one structural condition in which blood pressure matters. In a dilated proximal aorta, as in Marfan syndrome, the authors wrote that increases in blood pressure "can further exacerbate the dilatation" of the aorta.⁹

What the congenital heart disease data show

Pierick and colleagues reviewed the charts of patients aged 4 to 21 with congenital heart disease who received ADHD treatment over 5 years at a single centre, excluding trivial or spontaneously resolved disease. Among 831 who received stimulants, with a mean age of 12.9 years and a median follow-up of 686 days, one adverse cardiovascular event was identified. It was more frequent supraventricular tachycardia in a patient who had the condition before treatment, and it improved when ADHD treatment stopped.⁵ The authors called for population-based studies to validate the result.⁵

A 2023 review of 11 articles concluded that in mild congenital conditions (ventricular septal defect, atrial septal defect and isolated semilunar valve disease), "paediatricians can safely initiate stimulant therapy," and that cardiology opinion is recommended before stimulants in complex disease.¹⁰ A 2016 expert review suggested consultation with a pediatric cardiologist for any child with known cardiac disease.¹¹

A population-based cohort of children and adolescents grouped congenital heart disease, cardiomyopathy and valve disorders with cancer, HIV and anemias as high risk. In that group there were 26 serious cardiovascular events, 63 per 100,000 patient-years, with an odds ratio of 1.02 (95% CI, 0.28 to 3.69) for stimulant use.¹² The interval is wide enough to include a substantial increase or decrease.

Long QT syndrome

Long QT syndrome is an inherited rhythm condition. In a medical record review of 357 children with it, evaluated from 1999 to 2014, stimulants were stopped or advised against in 19 of the 28 with ADHD (68%). None of the 15 stimulant-treated patients had a long QT-triggered event over a combined 56 person-years, and 86% of those 28 were on beta-blockers.¹³

For adults with congenital heart disease, a PubMed search in November 2026 found only a single teaching case.¹⁴

Limitations of the evidence

This evidence has limitations. First, the congenital heart disease data come mostly from children, from one centre without an untreated comparison group, and from reviews. Second, no study of mitral valve prolapse was found, and the long QT series had 15 treated patients. Nevertheless, NICE and the reviews describe a sequence: a murmur or known structural finding leads to a cardiology opinion before the first dose, and two reviews describe common mild lesions as compatible with stimulant treatment.

The labels also tell patients to report exertional chest pain or unexplained fainting during treatment right away.^{1, 2, 3, 4} Chest pain, fainting or shortness of breath means calling 911 or going to an emergency department. For a known structural heart condition, the decision to start is made with the cardiologist before the first prescription.

Chest pain, fainting, or shortness of breath during treatment needs immediate medical assessment. Call 911 or go to the nearest emergency department for severe symptoms. Medication changes are made with the prescriber.

Related: Effects of ADHD medication on the heart · The long-term heart risk study · ADHD medication with high blood pressure · Heart palpitations · Children's heart safety · Heart attack and stroke · Adderall vs Ritalin · Raynaud's and cold hands · Heart rate on stimulants · Chest pain and cardiomyopathy · ADHD medication and POTS · ADHD medication after 50 · Exercise on ADHD medication